| NPRTX | VIVAX | NPRTX / VIVAX | |
| Total Expense Ratio | 0.76 | 0.17 | 447% |
| Annual Report Gross Expense Ratio | 0.76 | 0.17 | 447% |
| Fund Existence | 51 years | 33 years | - |
| Gain YTD | 17.157 | 11.965 | 143% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 8.56B | 208B | 4% |
| Annual Yield % from dividends | 1.90 | 1.98 | 96% |
| Returns for 1 year | 11.98 | 6.68 | 179% |
| Returns for 3 years | 26.15 | 33.49 | 78% |
| Returns for 5 years | 73.51 | 66.34 | 111% |
| Returns for 10 years | 115.89 | 135.00 | 86% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TOIIX | 20.28 | 0.21 | +1.05% |
| Touchstone International Value Instl | |||
| PIDIX | 14.21 | 0.09 | +0.64% |
| Principal International EQ Index Instl | |||
| RNPAX | 68.67 | 0.22 | +0.32% |
| American Funds New Perspective R1 | |||
| FCVAX | 19.49 | N/A | N/A |
| Fidelity Advisor Small Cap Value A | |||
| DTGCX | 38.60 | -0.06 | -0.16% |
| BNY Mellon Technology Growth C | |||